In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
New measures to limit the unavailability of medicines – Impact on professional stakeholders

New measures to limit the unavailability of medicines – Impact on professional stakeholders

by In2Pharma | Jun 7, 2019 | News

Belgium On 18 May 2019, a new law amending the law of 25 March 1964 on medicines entered into force. This amendment should reduce one of the causes of the temporary unavailability of certain medicines for Belgian patients. It intends to do so by preventing that...

Recent Posts

  • Price display of OTC medicines
  • New fees for food supplement notifications
  • Revision IML Code of Ethics
  • New guideline on the use of D-mannose in food supplements
  • Adjusted fees for applications to EMA

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België